Related Experiment Videos
Intraventricular hemorrhage in the preterm infant
Early Human Development
|January 5, 1996
Summary
Low-dose indomethacin given to premature infants can prevent intraventricular hemorrhage (IVH), a common brain bleed. This treatment reduces the incidence of all grades of IVH in the first five days of life.
Area of Science:
- Neonatal Medicine
- Pediatric Neurology
Background:
- Intraventricular hemorrhage (IVH) is a significant cause of morbidity in premature infants.
- Risk factors include vaginal delivery, labor, intrapartum asphyxia, and Respiratory Distress Syndrome.
- Antenatal steroid exposure may offer protection against IVH.
Purpose of the Study:
- To evaluate the efficacy of low-dose indomethacin in preventing intraventricular hemorrhage (IVH) in premature infants.
- To assess the impact of indomethacin on the incidence of all grades of IVH within the first five days of life.
Main Methods:
- Administration of low-dose indomethacin (0.1 mg/kg i.v.) at 6-12 postnatal hours.
- Two additional doses administered every 24 hours.
- Diagnosis of IVH confirmed by cranial ultrasound in the newborn special care unit.
Main Results:
- Low-dose indomethacin significantly decreased the incidence of all grades of intraventricular hemorrhage (IVH).
- The protective effect was observed within the first five days of life.
Conclusions:
- Low-dose indomethacin is an effective pharmacologic intervention for reducing the incidence of IVH in premature infants.
- Further innovative research is needed to further decrease IVH rates in neonates.